TreeWAS – Variant ID: rs9408926

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H26.9 Cataract, unspecified	0.000	0.950	0.050
H26 Other cataract	0.000	0.952	0.048
H26.4 After-cataract	0.000	0.955	0.045
H26.8 Other specified cataract	0.000	0.958	0.042
H26.1 Traumatic cataract	0.000	0.960	0.040
H26.0 Infantile, juvenile and presenile cataract	0.000	0.963	0.037
H26.2 Complicated cataract	0.000	0.964	0.036
H26.3 Drug-induced cataract	0.000	0.965	0.034
Z43.1 Attention to gastrostomy	0.016	0.984	0.000
Z43 Attention to artificial openings	0.016	0.984	0.000
Z43.6 Attention to other artificial openings of urinary tract	0.016	0.984	0.000
Z43.3 Attention to colostomy	0.014	0.986	0.000
Z43.4 Attention to other artificial openings of digestive tract	0.014	0.986	0.000
Z43.5 Attention to cyctostomy	0.014	0.986	0.000
Z43.0 Attention to tracheostomy	0.013	0.987	0.000
Z43.9 Attention to unspecified artificial opening	0.012	0.988	0.000
Z43.7 Attention to artificial vagina	0.012	0.988	0.000
Z43.8 Attention to other artificial openings	0.011	0.989	0.000
H25-H28 Disorders of lens	0.000	0.990	0.010
S82.20 Fracture of shaft of tibia (closed)	0.010	0.990	0.000
H27 Other disorders of lens	0.000	0.992	0.008
H28 Cataract and other disorders of lens in diseases classified elsewhere	0.000	0.992	0.008
H27.8 Other specified disorders of lens	0.000	0.993	0.007
H27.0 Aphakia	0.000	0.993	0.007
R19.8 Other specified symptoms and signs involving the digestive system and abdomen	0.000	0.994	0.006
H27.9 Disorder of lens, unspecified	0.000	0.994	0.006
H28.8 Other disorders of lens in diseases classified elsewhere	0.000	0.994	0.006
H28.2 Cataract in other diseases classified elsewhere	0.000	0.994	0.006
H28.1 Cataract in other endocrine, nutritional and metabolic diseases	0.000	0.994	0.006
H28.0 Diabetic cataract	0.000	0.994	0.006
H27.1 Dislocation of lens	0.000	0.994	0.005
Z43.2 Attention to ileostomy	0.005	0.995	0.000
L98.0 Pyogenic granuloma	0.005	0.995	0.000
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.000	0.995	0.005
M48.06 Spinal stenosis (Lumbar region)	0.000	0.995	0.005
S82.2 Fracture of shaft of tibia	0.005	0.995	0.000
Z90.5 Acquired absence of kidney	0.000	0.995	0.005
M10.99 Gout, unspecified (Site unspecified)	0.004	0.996	0.000
T39.1 4-Aminophenol derivatives	0.000	0.996	0.004
E66.8 Other obesity	0.000	0.996	0.004
S82.21 Fracture of shaft of tibia (open)	0.004	0.996	0.000
M43.16 Spondylolisthesis (Lumbar region)	0.000	0.996	0.004
L98 Other disorders of skin and subcutaneous tissue, not elsewhere classified	0.003	0.997	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.997	0.003
K70.0 Alcoholic fatty liver	0.003	0.997	0.000
M48.0 Spinal stenosis	0.000	0.997	0.003
T43.2 Other and unspecified antidepressants	0.000	0.997	0.003
L98.8 Other specified disorders of skin and subcutaneous tissue	0.003	0.997	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.997	0.003
I35.0 Aortic (valve) stenosis	0.000	0.997	0.003
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.997	0.003
K70 Alcoholic liver disease	0.003	0.997	0.000
D68.2 Hereditary deficiency of other clotting factors	0.003	0.997	0.000
K70.9 Alcoholic liver disease, unspecified	0.003	0.997	0.000
K70.3 Alcoholic cirrhosis of liver	0.003	0.997	0.000
M48.02 Spinal stenosis (Cervical region)	0.000	0.997	0.003
K70.2 Alcoholic fibrosis and sclerosis of liver	0.003	0.997	0.000
Q38.7 Pharyngeal pouch	0.003	0.997	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.997	0.003
M48.07 Spinal stenosis (Lumbosacral region)	0.000	0.997	0.003
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.997	0.003
R07.2 Precordial pain	0.000	0.997	0.003
C45.0 Mesothelioma of pleura	0.003	0.997	0.000
L98.7 Excessive and redundant skin and subcutaneous tissue	0.003	0.997	0.000
L98.6 Other infiltrative disorders of skin and subcutaneous tissue	0.003	0.997	0.000
L98.5 Mucinosis of skin	0.003	0.997	0.000
L98.3 Eosinophilic cellulitis [Wells]	0.003	0.997	0.000
L98.2 Febrile neutrophilic dermatosis [Sweet]	0.003	0.997	0.000
L98.1 Factitial dermatitis	0.003	0.997	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.997	0.003
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.997	0.003
T39.4 Antirheumatics, not elsewhere classified	0.000	0.997	0.003
T39.2 Pyrazolone derivatives	0.000	0.997	0.003
M48.08 Spinal stenosis (Sacral and sacrococcygeal region)	0.000	0.997	0.003
M48.05 Spinal stenosis (Thoracolumbar region)	0.000	0.997	0.003
M48.04 Spinal stenosis (Thoracic region)	0.000	0.997	0.003
M48.03 Spinal stenosis (Cervicothoracic region)	0.000	0.997	0.003
M48.01 Spinal stenosis (Occipito-atlanto-axial region)	0.000	0.997	0.003
M48.00 Spinal stenosis (Multiple sites in spine)	0.000	0.997	0.003
T39.0 Salicylates	0.000	0.997	0.003
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.997	0.003
L98.4 Chronic ulcer of skin, not elsewhere classified	0.003	0.997	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.997	0.002
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.997	0.002
T43.6 Psychostimulants with abuse potential	0.000	0.997	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.997	0.002
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.997	0.002
D12.4 Descending colon	0.000	0.997	0.003
T93.2 Sequelae of other fractures of lower limb	0.003	0.997	0.000
M48.09 Spinal stenosis (Site unspecified)	0.000	0.997	0.002
K70.1 Alcoholic hepatitis	0.002	0.997	0.000
L81.4 Other melanin hyperpigmentation	0.003	0.997	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.997	0.003
K70.4 Alcoholic hepatic failure	0.002	0.998	0.000
J31.0 Chronic rhinitis	0.000	0.998	0.002
M10.9 Gout, unspecified	0.002	0.998	0.000
T93.8 Sequelae of other specified injuries of lower limb	0.002	0.998	0.000
L40.9 Psoriasis, unspecified	0.002	0.998	0.000
L98.9 Disorder of skin and subcutaneous tissue, unspecified	0.002	0.998	0.000
T93 Sequelae of injuries of lower limb	0.002	0.998	0.000
Q38 Other congenital malformations of tongue, mouth and pharynx	0.002	0.998	0.000
C45.9 Mesothelioma, unspecified	0.002	0.998	0.000
S32.00 Fracture of lumbar vertebra (closed)	0.000	0.998	0.002
M10.90 Gout, unspecified (Multiple sites)	0.002	0.998	0.000
C45 Mesothelioma	0.002	0.998	0.000
S00.8 Superficial injury of other parts of head	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
D12.3 Transverse colon	0.000	0.998	0.002
T93.0 Sequelae of open wound of lower limb	0.002	0.998	0.000
Z45.0 Adjustment and management of cardiac pacemaker	0.000	0.998	0.002
L40 Psoriasis	0.002	0.998	0.000
L40.5 Arthropathic psoriasis	0.002	0.998	0.000
D12.6 Colon, unspecified	0.000	0.998	0.002
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.998	0.002
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.998	0.002
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.998	0.002
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.998	0.002
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.998	0.002
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T36 Poisoning by systemic antibiotics	0.000	0.998	0.002
L40.0 Psoriasis vulgaris	0.002	0.998	0.000
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.998	0.002
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
T93.1 Sequelae of fracture of femur	0.002	0.998	0.000
M10.98 Gout, unspecified (Other)	0.002	0.998	0.000
M10.95 Gout, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M10.94 Gout, unspecified (Hand)	0.002	0.998	0.000
M10.93 Gout, unspecified (Forearm)	0.002	0.998	0.000
M10.92 Gout, unspecified (Upper arm)	0.002	0.998	0.000
M10.91 Gout, unspecified (Shoulder region)	0.002	0.998	0.000
D68.9 Coagulation defect, unspecified	0.002	0.998	0.000
D68.5 Primary Thrombophilia	0.002	0.998	0.000
D68 Other coagulation defects	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.998	0.002
L81 Other disorders of pigmentation	0.002	0.998	0.000
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb	0.002	0.998	0.000
T93.5 Sequelae of injury of muscle and tendon of lower limb	0.002	0.998	0.000
T93.4 Sequelae of injury of nerve of lower limb	0.002	0.998	0.000
T93.9 Sequelae of unspecified injury of lower limb	0.002	0.998	0.000
L89 Decubitus ulcer	0.002	0.998	0.000
M10.97 Gout, unspecified (Ankle and foot)	0.002	0.998	0.000
Q38.8 Other congenital malformations of pharynx	0.002	0.998	0.000
Q38.6 Other congenital malformations of mouth	0.002	0.998	0.000
Q38.5 Congenital malformations of palate, not elsewhere classified	0.002	0.998	0.000
Q38.4 Congenital malformations of salivary glands and ducts	0.002	0.998	0.000
Q38.3 Other congenital malformations of tongue	0.002	0.998	0.000
Q38.2 Macroglossia	0.002	0.998	0.000
Q38.1 Ankyloglossia	0.002	0.998	0.000
Q38.0 Congenital malformations of lips, not elsewhere classified	0.002	0.998	0.000
L89.9 Decubitus ulcer and pressure area, unspecified	0.002	0.998	0.000
R19 Other symptoms and signs involving the digestive system and abdomen	0.000	0.998	0.002
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.998	0.002
Z08.7 Follow-up examination after combined treatment for malignant neoplasm	0.000	0.998	0.002
M25.46 Effusion of joint (Lower leg)	0.002	0.998	0.000
C45.2 Mesothelioma of pericardium	0.002	0.998	0.000
C45.1 Mesothelioma of peritoneum	0.002	0.998	0.000
L89.1 Stage II decubitus ulcer	0.002	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.998	0.002
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.000	0.998	0.002
C45.7 Mesothelioma of other sites	0.002	0.998	0.000
L89.0 Stage I decubitus ulcer and pressure area	0.002	0.998	0.000
T17.2 Foreign body in pharynx	0.002	0.998	0.000
T50.8 Diagnostic agents	0.000	0.998	0.002
T50.7 Analeptics and opioid receptor antagonists	0.000	0.998	0.002
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.998	0.002
T50.5 Appetite depressants	0.000	0.998	0.002
T50.4 Drugs affecting uric acid metabolism	0.000	0.998	0.002
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.998	0.002
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.998	0.002
T50.1 Loop [high-ceiling] diuretics	0.000	0.998	0.002
T50.0 Mineralocorticoids and their antagonists	0.000	0.998	0.002
Q38-Q45 Other congenital malformations of the digestive system	0.002	0.998	0.000
D68.6 Other Thrombophilia	0.002	0.998	0.000
L40.8 Other psoriasis	0.002	0.998	0.000
L40.4 Guttate psoriasis	0.002	0.998	0.000
L40.3 Pustulosis palmaris et plantaris	0.002	0.998	0.000
L40.2 Acrodermatitis continua	0.002	0.998	0.000
L40.1 Generalised pustular psoriasis	0.002	0.998	0.000
L89.3 Stage IV decubitus ulcer	0.002	0.998	0.000
L95.9 Vasculitis limited to skin, unspecified	0.002	0.998	0.000
R42 Dizziness and giddiness	0.000	0.998	0.002
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.998	0.002
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.998	0.002
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.998	0.002
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.998	0.002
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.998	0.002
T44.0 Anticholinesterase agents	0.000	0.998	0.002
L81.8 Other specified disorders of pigmentation	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.998	0.002
T36.8 Other systemic antibiotics	0.000	0.998	0.002
T36.7 Antifungal antibiotics, systemically used	0.000	0.998	0.002
T36.6 Rifamycins	0.000	0.998	0.002
T36.5 Aminoglycosides	0.000	0.998	0.002
T36.4 Tetracyclines	0.000	0.998	0.002
T36.3 Macrolides	0.000	0.998	0.002
T36.2 Chloramphenicol group	0.000	0.998	0.002
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.998	0.002
T36.0 Penicillins	0.000	0.998	0.002
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.998	0.002
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.998	0.002
T37.5 Antiviral drugs	0.000	0.998	0.002
T37.4 Anthelminthics	0.000	0.998	0.002
T37.3 Other antiprotozoal drugs	0.000	0.998	0.002
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.998	0.002
T37.1 Antimycobacterial drugs	0.000	0.998	0.002
T37.0 Sulphonamides	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.002
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.998	0.002
T38.7 Androgens and anabolic congeners	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.000	0.998	0.002
T38.4 Oral contraceptives	0.000	0.998	0.002
T38.2 Antithyroid drugs	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.002
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.002
T41.5 Therapeutic gases	0.000	0.998	0.002
T41.4 Anaesthetic, unspecified	0.000	0.998	0.002
T41.3 Local anaesthetics	0.000	0.998	0.002
T41.2 Other and unspecified general anaesthetics	0.000	0.998	0.002
T41.1 Intravenous anaesthetics	0.000	0.998	0.002
T41.0 Inhaled anaesthetics	0.000	0.998	0.002
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.998	0.002
T45.8 Other primarily systemic and haematological agents	0.000	0.998	0.002
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
T45.6 Fibrinolysis-affecting drugs	0.000	0.998	0.002
T45.5 Anticoagulants	0.000	0.998	0.002
T45.4 Iron and its compounds	0.000	0.998	0.002
T45.3 Enzymes, not elsewhere classified	0.000	0.998	0.002
T45.2 Vitamins, not elsewhere classified	0.000	0.998	0.002
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.998	0.002
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.998	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.998	0.002
T47.7 Emetics	0.000	0.998	0.002
T47.6 Antidiarrhoeal drugs	0.000	0.998	0.002
T47.5 Digestants	0.000	0.998	0.002
T47.4 Other laxatives	0.000	0.998	0.002
T47.3 Saline and osmotic laxatives	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.998	0.002
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.998	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.998	0.002
T48.5 Anti-common-cold drugs	0.000	0.998	0.002
T48.4 Expectorants	0.000	0.998	0.002
T48.3 Antitussives	0.000	0.998	0.002
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.998	0.002
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.998	0.002
T48.0 Oxytocic drugs	0.000	0.998	0.002
T49.9 Topical agent, unspecified	0.000	0.998	0.002
T49.8 Other topical agents	0.000	0.998	0.002
T49.7 Dental drugs, topically applied	0.000	0.998	0.002
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.998	0.002
T49.5 Ophthalmological drugs and preparations	0.000	0.998	0.002
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.998	0.002
T49.3 Emollients, demulcents and protectants	0.000	0.998	0.002
T49.2 Local astringents and local detergents	0.000	0.998	0.002
T49.1 Antipruritics	0.000	0.998	0.002
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.998	0.002
Q40 Other congenital malformations of upper alimentary tract	0.002	0.998	0.000
D68.4 Acquired coagulation factor deficiency	0.002	0.998	0.000
D68.1 Hereditary factor XI deficiency	0.002	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.002
L81.7 Pigmented purpuric dermatosis	0.002	0.998	0.000
L81.6 Other disorders of diminished melanin formation	0.002	0.998	0.000
L81.5 Leukoderma, not elsewhere classified	0.002	0.998	0.000
L81.3 Cafe au lait spots	0.002	0.998	0.000
L81.2 Freckles	0.002	0.998	0.000
L81.1 Chloasma	0.002	0.998	0.000
L81.0 Postinflammatory hyperpigmentation	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
T45.0 Antiallergic and antiemetic drugs	0.000	0.998	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.998	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.998	0.002
T46.7 Peripheral vasodilators	0.000	0.998	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.998	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.998	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.000	0.998	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.998	0.002
L95 Vasculitis limited to skin, not elsewhere classified	0.002	0.998	0.000
Q40.2 Other specified congenital malformations of stomach	0.002	0.998	0.000
M48 Other spondylopathies	0.000	0.998	0.002
I35.9 Aortic valve disorder, unspecified	0.000	0.998	0.002
M18 Arthrosis of first carpometacarpal joint	0.000	0.998	0.002
Q44 Congenital malformations of gallbladder, bile ducts and liver	0.002	0.998	0.000
R19.6 Halitosis	0.000	0.998	0.002
R19.3 Abdominal rigidity	0.000	0.998	0.002
R19.2 Visible peristalsis	0.000	0.998	0.002
R19.1 Abnormal bowel sounds	0.000	0.998	0.002
L80-L99 Other disorders of the skin and subcutaneous tissue	0.002	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.001
M10.96 Gout, unspecified (Lower leg)	0.001	0.998	0.000
M54.12 Radiculopathy (Cervical region)	0.000	0.998	0.002
D12.7 Rectosigmoid junction	0.000	0.998	0.002
R19.0 Intra-abdominal and pelvic swelling, mass and lump	0.000	0.998	0.002
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.998	0.001
T40.8 Lysergide [LSD]	0.000	0.998	0.001
T40.7 Cannabis (derivatives)	0.000	0.998	0.001
T40.6 Other and unspecified narcotics	0.000	0.998	0.001
T40.5 Cocaine	0.000	0.998	0.001
T40.3 Methadone	0.000	0.998	0.001
T40.1 Heroin	0.000	0.998	0.001
T40.0 Opium	0.000	0.998	0.001
D12.1 Appendix	0.000	0.998	0.001
D68.8 Other specified coagulation defects	0.001	0.998	0.000
L94 Other localised connective tissue disorders	0.002	0.998	0.000
M76.67 Achilles tendinitis (Ankle and foot)	0.002	0.998	0.000
K55.2 Angiodysplasia of colon	0.000	0.998	0.002
K63.8 Other specified diseases of intestine	0.000	0.998	0.002
R19.5 Other fecal abnormalities	0.000	0.998	0.002
Q45 Other congenital malformations of digestive system	0.001	0.998	0.000
Q43 Other congenital malformations of intestine	0.001	0.998	0.000
Q42 Congenital absence, atresia and stenosis of large intestine	0.001	0.998	0.000
Q41 Congenital absence, atresia and stenosis of small intestine	0.001	0.998	0.000
Q39 Congenital malformations of oesophagus	0.001	0.998	0.000
O02.1 Missed abortion	0.000	0.998	0.002
A49.0 Staphylococcal infection, unspecified	0.000	0.998	0.002
L81.9 Disorder of pigmentation, unspecified	0.001	0.998	0.000
L94.9 Localised connective tissue disorder, unspecified	0.001	0.998	0.000
Q44.6 Cystic disease of liver	0.001	0.998	0.000
M48.5 Collapsed vertebra, not elsewhere classified	0.000	0.998	0.001
Q40.9 Congenital malformation of upper alimentary tract, unspecified	0.001	0.998	0.000
Q40.8 Other specified congenital malformations of upper alimentary tract	0.001	0.998	0.000
Q40.3 Congenital malformation of stomach, unspecified	0.001	0.998	0.000
Q40.1 Congenital hiatus hernia	0.001	0.998	0.000
Q40.0 Congenital hypertrophic pyloric stenosis	0.001	0.998	0.000
T40.4 Other synthetic narcotics	0.000	0.998	0.001
T90.0 Sequelae of superficial injury of head	0.001	0.998	0.000
L83 Acanthosis nigricans	0.001	0.998	0.000
L95.8 Other vasculitis limited to skin	0.001	0.998	0.000
L95.1 Erythema elevatum diutinum	0.001	0.998	0.000
L95.0 Livedoid vasculitis	0.001	0.998	0.000
M48.9 Spondylopathy, unspecified	0.000	0.998	0.001
M48.8 Other specified spondylopathies	0.000	0.998	0.001
M48.4 Fatigue fracture of vertebra	0.000	0.998	0.001
M48.3 Traumatic spondylopathy	0.000	0.998	0.001
M48.2 Kissing spine	0.000	0.998	0.001
M48.1 Ankylosing hyperostosis [Forestier]	0.000	0.998	0.001
M70.65 Trochanteric bursitis-Pelvic/Thigh	0.001	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.998	0.001
M13.95 Arthritis, unspecified (Pelvic region and thigh)	0.000	0.999	0.001
D68.3 Haemorrhagic disorder due to circulating anticoagulants	0.001	0.999	0.000
M18.5 Other secondary arthrosis of first carpometacarpal joint	0.000	0.999	0.001
M18.4 Other secondary arthrosis of first carpometacarpal joints, bilateral	0.000	0.999	0.001
M18.3 Other posttraumatic arthrosis of first carpometacarpal joint	0.000	0.999	0.001
M18.2 Posttraumatic arthrosis of first carpometacarpal joints, bilateral	0.000	0.999	0.001
Q44.7 Other congenital malformations of liver	0.001	0.999	0.000
Q44.5 Other congenital malformations of bile ducts	0.001	0.999	0.000
Q44.4 Choledochal cyst	0.001	0.999	0.000
Q44.3 Congenital stenosis and stricture of bile ducts	0.001	0.999	0.000
Q44.2 Atresia of bile ducts	0.001	0.999	0.000
Q44.1 Other congenital malformations of gallbladder	0.001	0.999	0.000
Q44.0 Agenesis, aplasia and hypoplasia of gallbladder	0.001	0.999	0.000
I35 Nonrheumatic aortic valve disorders	0.000	0.999	0.001
L99 Other disorders of skin and subcutaneous tissue in diseases classified elsewhere	0.001	0.999	0.000
L87 Transepidermal elimination disorders	0.001	0.999	0.000
L88 Pyoderma gangrenosum	0.001	0.999	0.000
L86 Keratoderma in diseases classified elsewhere	0.001	0.999	0.000
D68.0 Von Willebrand's disease	0.001	0.999	0.000
M18.0 Primary arthrosis of first carpometacarpal joints, bilateral	0.000	0.999	0.001
M43.1 Spondylolisthesis	0.000	0.999	0.001
T90.9 Sequelae of unspecified injury of head	0.001	0.999	0.000
L80 Vitiligo	0.001	0.999	0.000
S92.30 Fracture of metatarsal bone (closed)	0.000	0.999	0.001
L92.0 Granuloma annulare	0.001	0.999	0.000
D12.8 Rectum	0.000	0.999	0.001
D12.5 Sigmoid colon	0.000	0.999	0.001
L89.2 Stage III decubitus ulcer	0.001	0.999	0.000
Q43.9 Congenital malformation of intestine, unspecified	0.001	0.999	0.000
Q43.0 Meckel's diverticulum	0.001	0.999	0.000
M48.54 Collapsed vertebra, not elsewhere classified (Thoracic region)	0.000	0.999	0.001
I86.4 Gastric varices	0.001	0.999	0.000
L94.8 Other specified localised connective tissue disorders	0.001	0.999	0.000
L94.6 Ainhum	0.001	0.999	0.000
L94.5 Poikiloderma vasculare atrophicans	0.001	0.999	0.000
L94.4 Gottron's papules	0.001	0.999	0.000
L94.3 Sclerodactyly	0.001	0.999	0.000
L94.2 Calcinosis cutis	0.001	0.999	0.000
L94.1 Linear scleroderma	0.001	0.999	0.000
L94.0 Localised scleroderma [morphea]	0.001	0.999	0.000
M16.1 Other primary coxarthrosis	0.000	0.999	0.001
Q39.9 Congenital malformation of oesophagus, unspecified	0.001	0.999	0.000
Q39.8 Other congenital malformations of oesophagus	0.001	0.999	0.000
Q39.6 Diverticulum of oesophagus	0.001	0.999	0.000
Q39.5 Congenital dilatation of oesophagus	0.001	0.999	0.000
Q39.4 Oesophageal web	0.001	0.999	0.000
Q39.3 Congenital stenosis and stricture of oesophagus	0.001	0.999	0.000
Q39.2 Congenital tracheooesophageal fistula without atresia	0.001	0.999	0.000
Q39.1 Atresia of oesophagus with tracheooesophageal fistula	0.001	0.999	0.000
Q39.0 Atresia of oesophagus without fistula	0.001	0.999	0.000
Q41.9 Congenital absence, atresia and stenosis of small intestine, part unspecified	0.001	0.999	0.000
Q41.8 Congenital absence, atresia and stenosis of other specified parts of small intestine	0.001	0.999	0.000
Q41.2 Congenital absence, atresia and stenosis of ileum	0.001	0.999	0.000
Q41.1 Congenital absence, atresia and stenosis of jejunum	0.001	0.999	0.000
Q41.0 Congenital absence, atresia and stenosis of duodenum	0.001	0.999	0.000
Q42.9 Congenital absence, atresia and stenosis of large intestine, part unspecified	0.001	0.999	0.000
Q42.8 Congenital absence, atresia and stenosis of other parts of large intestine	0.001	0.999	0.000
Q42.3 Congenital absence, atresia and stenosis of anus without fistula	0.001	0.999	0.000
Q42.2 Congenital absence, atresia and stenosis of anus with fistula	0.001	0.999	0.000
Q42.1 Congenital absence, atresia and stenosis of rectum without fistula	0.001	0.999	0.000
Q42.0 Congenital absence, atresia and stenosis of rectum with fistula	0.001	0.999	0.000
Q43.7 Persistent cloaca	0.001	0.999	0.000
Q43.6 Congenital fistula of rectum and anus	0.001	0.999	0.000
Q43.5 Ectopic anus	0.001	0.999	0.000
Q43.4 Duplication of intestine	0.001	0.999	0.000
Q43.3 Congenital malformations of intestinal fixation	0.001	0.999	0.000
Q43.2 Other congenital functional disorders of colon	0.001	0.999	0.000
Q43.1 Hirschsprung's disease	0.001	0.999	0.000
Q45.9 Congenital malformation of digestive system, unspecified	0.001	0.999	0.000
Q45.8 Other specified congenital malformations of digestive system	0.001	0.999	0.000
Q45.3 Other congenital malformations of pancreas and pancreatic duct	0.001	0.999	0.000
Q45.2 Congenital pancreatic cyst	0.001	0.999	0.000
Q45.1 Annular pancreas	0.001	0.999	0.000
Q45.0 Agenesis, aplasia and hypoplasia of pancreas	0.001	0.999	0.000
T18.1 Foreign body in oesophagus	0.001	0.999	0.000
L92 Granulomatous disorders of skin and subcutaneous tissue	0.001	0.999	0.000
T90 Sequelae of injuries of head	0.001	0.999	0.000
S32.0 Fracture of lumbar vertebra	0.000	0.999	0.001
T40.2 Other opioids	0.000	0.999	0.001
T17 Foreign body in respiratory tract	0.001	0.999	0.000
M48.59 Collapsed vertebra, not elsewhere classified (Site unspecified)	0.000	0.999	0.001
M48.58 Collapsed vertebra, not elsewhere classified (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M48.57 Collapsed vertebra, not elsewhere classified (Lumbosacral region)	0.000	0.999	0.001
M48.55 Collapsed vertebra, not elsewhere classified (Thoracolumbar region)	0.000	0.999	0.001
M48.53 Collapsed vertebra, not elsewhere classified (Cervicothoracic region)	0.000	0.999	0.001
M48.52 Collapsed vertebra, not elsewhere classified (Cervical region)	0.000	0.999	0.001
M48.51 Collapsed vertebra, not elsewhere classified (Occipito-atlanto-axial region)	0.000	0.999	0.001
M48.50 Collapsed vertebra, not elsewhere classified (Multiple sites in spine)	0.000	0.999	0.001
D12.9 Anus and anal canal	0.000	0.999	0.001
T90.2 Sequelae of fracture of skull and facial bones	0.001	0.999	0.000
A49.8 Other bacterial infections of unspecified site	0.000	0.999	0.001
L93 Lupus erythematosus	0.001	0.999	0.000
M48.19 Ankylosing hyperostosis [Forestier] (Site unspecified)	0.000	0.999	0.001
M48.18 Ankylosing hyperostosis [Forestier] (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M48.17 Ankylosing hyperostosis [Forestier] (Lumbosacral region)	0.000	0.999	0.001
M48.16 Ankylosing hyperostosis [Forestier] (Lumbar region)	0.000	0.999	0.001
M48.15 Ankylosing hyperostosis [Forestier] (Thoracolumbar region)	0.000	0.999	0.001
M48.14 Ankylosing hyperostosis [Forestier] (Thoracic region)	0.000	0.999	0.001
M48.13 Ankylosing hyperostosis [Forestier] (Cervicothoracic region)	0.000	0.999	0.001
M48.12 Ankylosing hyperostosis [Forestier] (Cervical region)	0.000	0.999	0.001
M48.11 Ankylosing hyperostosis [Forestier] (Occipito-atlanto-axial region)	0.000	0.999	0.001
M48.10 Ankylosing hyperostosis [Forestier] (Multiple sites in spine)	0.000	0.999	0.001
M48.29 Kissing spine (Site unspecified)	0.000	0.999	0.001
M48.28 Kissing spine (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M48.27 Kissing spine (Lumbosacral region)	0.000	0.999	0.001
M48.26 Kissing spine (Lumbar region)	0.000	0.999	0.001
M48.25 Kissing spine (Thoracolumbar region)	0.000	0.999	0.001
M48.24 Kissing spine (Thoracic region)	0.000	0.999	0.001
M48.23 Kissing spine (Cervicothoracic region)	0.000	0.999	0.001
M48.22 Kissing spine (Cervical region)	0.000	0.999	0.001
M48.21 Kissing spine (Occipito-atlanto-axial region)	0.000	0.999	0.001
M48.20 Kissing spine (Multiple sites in spine)	0.000	0.999	0.001
M48.39 Traumatic spondylopathy (Site unspecified)	0.000	0.999	0.001
M48.38 Traumatic spondylopathy (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M48.37 Traumatic spondylopathy (Lumbosacral region)	0.000	0.999	0.001
M48.36 Traumatic spondylopathy (Lumbar region)	0.000	0.999	0.001
M48.35 Traumatic spondylopathy (Thoracolumbar region)	0.000	0.999	0.001
M48.34 Traumatic spondylopathy (Thoracic region)	0.000	0.999	0.001
M48.33 Traumatic spondylopathy (Cervicothoracic region)	0.000	0.999	0.001
M48.32 Traumatic spondylopathy (Cervical region)	0.000	0.999	0.001
M48.31 Traumatic spondylopathy (Occipito-atlanto-axial region)	0.000	0.999	0.001
M48.30 Traumatic spondylopathy (Multiple sites in spine)	0.000	0.999	0.001
M48.49 Fatigue fracture of vertebra (Site unspecified)	0.000	0.999	0.001
M48.48 Fatigue fracture of vertebra (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M48.47 Fatigue fracture of vertebra (Lumbosacral region)	0.000	0.999	0.001
M48.46 Fatigue fracture of vertebra (Lumbar region)	0.000	0.999	0.001
M48.45 Fatigue fracture of vertebra (Thoracolumbar region)	0.000	0.999	0.001
M48.44 Fatigue fracture of vertebra (Thoracic region)	0.000	0.999	0.001
M48.43 Fatigue fracture of vertebra (Cervicothoracic region)	0.000	0.999	0.001
M48.42 Fatigue fracture of vertebra (Cervical region)	0.000	0.999	0.001
M48.41 Fatigue fracture of vertebra (Occipito-atlanto-axial region)	0.000	0.999	0.001
M48.40 Fatigue fracture of vertebra (Multiple sites in spine)	0.000	0.999	0.001
M48.56 Collapsed vertebra, not elsewhere classified (Lumbar region)	0.000	0.999	0.001
M48.89 Other specified spondylopathies (Site unspecified)	0.000	0.999	0.001
M48.88 Other specified spondylopathies (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M48.87 Other specified spondylopathies (Lumbosacral region)	0.000	0.999	0.001
M48.86 Other specified spondylopathies (Lumbar region)	0.000	0.999	0.001
M48.85 Other specified spondylopathies (Thoracolumbar region)	0.000	0.999	0.001
M48.84 Other specified spondylopathies (Thoracic region)	0.000	0.999	0.001
M48.83 Other specified spondylopathies (Cervicothoracic region)	0.000	0.999	0.001
M48.82 Other specified spondylopathies (Cervical region)	0.000	0.999	0.001
M48.81 Other specified spondylopathies (Occipito-atlanto-axial region)	0.000	0.999	0.001
M48.80 Other specified spondylopathies (Multiple sites in spine)	0.000	0.999	0.001
M48.99 Spondylopathy, unspecified (Site unspecified)	0.000	0.999	0.001
M48.98 Spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M48.97 Spondylopathy, unspecified (Lumbosacral region)	0.000	0.999	0.001
M48.96 Spondylopathy, unspecified (Lumbar region)	0.000	0.999	0.001
M48.95 Spondylopathy, unspecified (Thoracolumbar region)	0.000	0.999	0.001
M48.94 Spondylopathy, unspecified (Thoracic region)	0.000	0.999	0.001
M48.93 Spondylopathy, unspecified (Cervicothoracic region)	0.000	0.999	0.001
M48.92 Spondylopathy, unspecified (Cervical region)	0.000	0.999	0.001
M48.91 Spondylopathy, unspecified (Occipito-atlanto-axial region)	0.000	0.999	0.001
M48.90 Spondylopathy, unspecified (Multiple sites in spine)	0.000	0.999	0.001
Q43.8 Other specified congenital malformations of intestine	0.001	0.999	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations